Santiago Perez-Lloret

Cited by

	All	Since 2020
Citations	8083	4113
h-index	46	32
i10-index	107	77

860

430

215

645

20052006200720082009201020112012201320142015201620172018201920202021202220232024202525 21 38 38 47 75 132 198 328 359 423 475 528 535 595 685 819 833 833 845 93

Public access

View all

26 articles

0 articles

available

not available

Based on funding mandates

Co-authors

Olivier RASCOLUT3 Professor, CHU Purpan, Tonic (INSERM-UT3), CIC 1436 (INSERM-CHU-UT3), TMBI (Univ. Toulouse)Verified email at univ-tlse3.fr
Marcelo MerelloProfessor of Neurology. UCA. Director Neuroscience Department FLENIVerified email at fleni.org.ar
Daniel P. CardinaliConicet, Pontificia Universidad Católica ArgentinaVerified email at uca.edu.ar
Jean-Louis MontastrucProfessor of Clinical Pharmacology Faculty of Medicine-University Hospital Toulouse FranceVerified email at univ-tlse3.fr
laurence NEGRE-PAGESVerified email at chu-montpellier.fr
Malco RossiFLENI - CONICETVerified email at fleni.org.ar
Wassilios MeissnerVerified email at chu-bordeaux.fr
Francisco CapaniInvestigador Asociado Universidad Autonoma de Chile and CAECHIS-UAI-CONICET, Buenos AiresVerified email at uautonoma.cl
Otero-Losada MatildePh D in Neuropharmacology. Res Sci National Research Council CONICET. Buenos Aires. ArgentinaVerified email at fmed.uba.ar
Anne PAVY LE TRAONHospital practitioner of neurology, CHU Purpan, Equipe 8 UMR1048 (Inserm-UT3), TMBI (Univ. Toulouse)Verified email at chu-toulouse.fr
Susan FoxAssociate Professor University of TorontoVerified email at uhnresearch.ca
Donald MattisonUniversity of South CarolinaVerified email at risksciences.com
Regina KatzenschlagerKlinik DonaustadtVerified email at chello.at
Daniel Eduardo VigoPontificia Universidad Católica Argentina - CONICET - KU LeuvenVerified email at conicet.gov.ar
Arnaud DelvalUniversité LilleVerified email at chru-lille.fr
Daniel Ciampi de Andrade, MD, PhD,...Center for Neuroplasticity and Pain, Fac. of Medicine, Aalborg University, Danmark.Verified email at hst.aau.dk
Werner PoeweProfessor NeurologieVerified email at i-med.ac.at
Patricio Millar VernettiFLENIVerified email at fleni.org.ar
christine Brefel-courbonMCU PH, Neuropharmacologie, CHU Toulouse; TONIC (INSERM UT3); TMBI Univ ToulouseVerified email at univ-tlse3.fr
Emmanuelle Bondon-GuittonPharmD, PhD, Service de Pharmacologie Médicale et Clinique du CHU de ToulouseVerified email at univ-tlse3.fr

Santiago Perez-Lloret

Pontificia Universidad Católica Argentina, Consejo de Investigaciones Científicas y Técnicas

Verified email at uca.edu.ar

Neurodegenerative diseases Parkinson's Disease pharmacology epidemiology public health


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the non‐motor symptoms of Parkinson's disease K Seppi, D Weintraub, M Coelho, S Perez‐Lloret, SH Fox, ... Movement disorders 26 (S3), S42-S80, 2011	1169	2011
Update on treatments for nonmotor symptoms of Parkinson's disease—an evidence‐based medicine review K Seppi, K Ray Chaudhuri, M Coelho, SH Fox, R Katzenschlager, ... Movement Disorders 34 (2), 180-198, 2019	979*	2019
Prevalence, determinants, and effect on quality of life of freezing of gait in Parkinson disease S Perez-Lloret, L Negre-Pages, P Damier, A Delval, P Derkinderen, ... JAMA neurology 71 (7), 884-890, 2014	341	2014
Sleep disordered breathing and daytime sleepiness are associated with poor academic performance in teenagers. A study using the Pediatric Daytime Sleepiness Scale (PDSS) D Perez-Chada, S Perez-Lloret, AJ Videla, D Cardinali, MA Bergna, ... Sleep 30 (12), 1698-1703, 2007	263	2007
Deficits in cholinergic neurotransmission and their clinical correlates in Parkinson’s disease S Perez-Lloret, FJ Barrantes NPJ Parkinson's disease 2 (1), 1-12, 2016	197	2016
Drug‐induced parkinsonism: a review of 17 years' experience in a regional pharmacovigilance center in France E Bondon‐Guitton, S Perez‐Lloret, H Bagheri, C Brefel, O Rascol, ... Movement disorders 26 (12), 2226-2231, 2011	188	2011
Autosomal dominant cerebellar ataxias: a systematic review of clinical features M Rossi, S Perez‐Lloret, L Doldan, D Cerquetti, J Balej, P Millar Vernetti, ... European Journal of Neurology 21 (4), 607-615, 2014	157	2014
New treatments for levodopa‐induced motor complications O Rascol, S Perez‐Lloret, JJ Ferreira Movement Disorders 30 (11), 1451-1460, 2015	150	2015
Decision‐making in Parkinson’s disease patients with and without pathological gambling M Rossi, ER Gerschcovich, D De Achaval, S Perez‐Lloret, D Cerquetti, ... European Journal of Neurology 17 (1), 97-102, 2010	145	2010
Dopamine receptor agonists for the treatment of early or advanced Parkinson’s disease S Perez-Lloret, O Rascol CNS drugs 24 (11), 941-968, 2010	142	2010
Sleep disruption in medicine students and its relationship with impaired academic performance: a systematic review and meta-analysis HA Seoane, L Moschetto, F Orliacq, J Orliacq, E Serrano, MI Cazenave, ... Sleep medicine reviews 53, 101333, 2020	130	2020
Addenbrooke’s Cognitive Examination validation in Parkinson’s disease MA Reyes, SP Lloret, ER Gerscovich, ME Martin, R Leiguarda, M Merello European Journal of Neurology 16 (1), 142-147, 2009	129	2009
Sensory abnormalities and pain in Parkinson disease and its modulation by treatment of motor symptoms RG Cury, R Galhardoni, ET Fonoff, S Pérez Lloret, ... European journal of pain 20 (2), 151-165, 2016	126	2016
A multi-step pathway connecting short sleep duration to daytime somnolence, reduced attention, and poor academic performance: an exploratory cross-sectional study in teenagers S Perez-Lloret, AJ Videla, A Richaudeau, D Vigo, M Rossi, DP Cardinali, ... Journal of Clinical Sleep Medicine 9 (5), 469-473, 2013	126	2013
Prevalence and pharmacological factors associated with impulse-control disorder symptoms in patients with Parkinson disease S Perez-Lloret, MV Rey, N Fabre, F Ory, U Spampinato, C Brefel-Courbon, ... Clinical neuropharmacology 35 (6), 261-265, 2012	117	2012
Oro‐buccal symptoms (dysphagia, dysarthria, and sialorrhea) in patients with Parkinson’s disease: preliminary analysis from the French COPARK cohort S Perez‐Lloret, L Nègre‐Pagès, A Ojero‐Senard, P Damier, A Destée, ... European journal of neurology 19 (1), 28-37, 2012	109	2012
Associations between anticholinergic burden and adverse health outcomes in Parkinson disease JAG Crispo, AW Willis, DP Thibault, Y Fortin, HD Hays, DS McNair, ... PLoS One 11 (3), e0150621, 2016	108	2016
Validation of a new scale for the evaluation of sialorrhea in patients with Parkinson's disease S Perez Lloret, G Pirán Arce, M Rossi, ML Caivano Nemet, P Salsamendi, ... Movement disorders 22 (1), 107-111, 2007	104	2007
Low urinary 6-sulfatoxymelatonin levels in patients with severe congestive heart failure L Girotti, M Lago, O Ianovsky, MV Elizari, A Dini, SP Lloret, LE Albornoz, ... Endocrine 22, 245-248, 2003	90	2003
A multifactorial approach employing melatonin to accelerate resynchronization of sleep–wake cycle after a 12 time‐zone westerly transmeridian flight in elite soccer athletes DP Cardinali, GP Bortman, G Liotta, SP Lloret, LE Albornoz, RA Cutrera, ... Journal of pineal research 32 (1), 41-46, 2002	90	2002

The system can't perform the operation now. Try again later.

Articles 1–20

Citations per year

Duplicate citations

Merged citations

Add co-authorsCo-authors

Follow

Cited by

Co-authors